ArTS Archivio della ricerca di Trieste

TIRIBELLI, CLAUDIO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 33.483
EU - Europa 13.991
AS - Asia 13.946
SA - Sud America 1.803
AF - Africa 406
OC - Oceania 64
Continente sconosciuto - Info sul continente non disponibili 34
Totale 63.727
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 33.005
SG - Singapore 5.242
PL - Polonia 3.315
CN - Cina 2.855
IT - Italia 2.149
UA - Ucraina 1.867
HK - Hong Kong 1.479
SE - Svezia 1.467
VN - Vietnam 1.432
BR - Brasile 1.405
DE - Germania 988
KR - Corea 757
FR - Francia 747
FI - Finlandia 697
TR - Turchia 636
GB - Regno Unito 575
RU - Federazione Russa 526
IE - Irlanda 408
BG - Bulgaria 391
IN - India 368
BD - Bangladesh 334
CA - Canada 289
NL - Olanda 268
AR - Argentina 148
JP - Giappone 113
MX - Messico 108
MA - Marocco 104
BE - Belgio 92
IQ - Iraq 91
ZA - Sudafrica 84
CH - Svizzera 80
PK - Pakistan 79
ID - Indonesia 76
SN - Senegal 71
ES - Italia 64
AT - Austria 59
IR - Iran 59
AU - Australia 55
DK - Danimarca 52
PH - Filippine 48
CL - Cile 47
EC - Ecuador 47
VE - Venezuela 47
SA - Arabia Saudita 44
CO - Colombia 37
EE - Estonia 34
CZ - Repubblica Ceca 33
TH - Thailandia 32
EG - Egitto 29
KE - Kenya 27
UZ - Uzbekistan 27
IL - Israele 25
JO - Giordania 25
LT - Lituania 25
MY - Malesia 25
PY - Paraguay 25
RO - Romania 25
DZ - Algeria 24
EU - Europa 24
TW - Taiwan 24
AE - Emirati Arabi Uniti 20
AZ - Azerbaigian 20
GR - Grecia 18
KZ - Kazakistan 18
PE - Perù 18
PT - Portogallo 15
RS - Serbia 15
TN - Tunisia 15
NP - Nepal 14
BO - Bolivia 13
LB - Libano 13
OM - Oman 13
UY - Uruguay 12
AL - Albania 11
CR - Costa Rica 11
JM - Giamaica 11
KG - Kirghizistan 11
NG - Nigeria 11
DO - Repubblica Dominicana 9
GE - Georgia 9
HR - Croazia 9
MD - Moldavia 9
PA - Panama 9
AM - Armenia 8
ET - Etiopia 8
HN - Honduras 8
HU - Ungheria 8
LK - Sri Lanka 8
NO - Norvegia 8
NZ - Nuova Zelanda 8
SI - Slovenia 8
SK - Slovacchia (Repubblica Slovacca) 8
A2 - ???statistics.table.value.countryCode.A2??? 7
GT - Guatemala 7
PS - Palestinian Territory 7
NI - Nicaragua 6
GA - Gabon 5
GH - Ghana 5
LA - Repubblica Popolare Democratica del Laos 5
LV - Lettonia 5
Totale 63.632
Salva come PNG Salva come JPEG
Città #
Woodbridge 3.267
Singapore 3.222
Fairfield 3.146
Ashburn 3.063
Warsaw 2.942
Ann Arbor 2.730
Houston 2.535
Chandler 2.170
Jacksonville 1.650
Wilmington 1.553
San Jose 1.491
Hong Kong 1.448
Seattle 1.361
Cambridge 1.058
Seoul 714
Princeton 703
Hefei 640
Beijing 600
Boardman 600
Trieste 540
Izmir 512
Chicago 475
Ho Chi Minh City 437
Dublin 397
Sofia 385
Columbus 367
Zgierz 347
Lauterbourg 346
Los Angeles 319
Hanoi 314
Milan 269
Dallas 244
New York 243
Santa Clara 235
Moscow 234
The Dalles 225
Buffalo 199
Frankfurt am Main 190
San Diego 185
Council Bluffs 179
Dearborn 158
Falls Church 158
Helsinki 149
Toronto 143
London 142
Munich 139
São Paulo 131
Des Moines 122
Atlanta 121
Düsseldorf 120
Brussels 85
Tokyo 85
Shanghai 77
Phoenix 74
Casablanca 73
Amsterdam 71
Dakar 71
Rome 66
Orem 65
Guangzhou 64
Redondo Beach 64
Montreal 63
Washington 59
Denver 56
Dong Ket 56
Redwood City 55
Da Nang 54
Miano 54
Nuremberg 54
Norwalk 53
Turku 53
Haiphong 52
Brooklyn 51
Kocaeli 51
Mumbai 49
Bremen 48
Rio de Janeiro 48
Verona 47
Copenhagen 45
Johannesburg 45
Bern 44
San Francisco 43
Kunming 40
Vienna 40
Chennai 35
Jinan 34
Nanjing 34
Stockholm 34
Tallinn 34
Boston 32
Belo Horizonte 30
Krefeld 30
Baghdad 29
Dhaka 28
Redmond 28
Indiana 27
Brasília 26
Curitiba 26
Manchester 26
Mexico City 26
Totale 45.352
Salva come PNG Salva come JPEG
Nome #
Bilirubin and inflammation in neurodegenerative and other neurological diseases 632
Brain Cytochrome p450 enzymes: a possible Therapeutic Targets for Neurological Diseases 453
The role of multipotent cancer associated fibroblasts in hepatocarcinogenesis 438
The biological effects of bilirubin photoisomers 432
An animal model for the juvenile non-alcoholic fatty liver disease and non-alcoholic steatohepatitis 430
Evaluation of region selective bilirubin-induced brain damage as a basis for a pharmacological treatment 419
Transcriptional Up-Regulation of APE1/Ref-1 in hepatic tumor: Role in hepatocytes resistance to oxidative stress and apoptosis 409
Effects of oral administration of silymarin in a juvenile murine model of non-alcoholic steatohepatitis 407
MicroRNAs as Regulators of Neo-Angiogenesis in Hepatocellular Carcinoma 403
Silencing efficacy prediction: a retrospective study on target mRNA features 389
Serum Stem Cell Growth Factor Beta for the Prediction of Therapy Response in Hepatocellular Carcinoma 389
Hepatitis C-related cryoglobulinemic neuropathy: Potential role of oxcarbazepine for pain control 384
International genome-wide meta-analysis identifies new primary biliary cirrhosis risk loci and targetable pathogenic pathways 365
Serum AP-endonuclease 1 (sAPE1) as novel biomarker for hepatocellular carcinoma 359
Histone acetylation as a new mechanism for bilirubin-induced encephalopathy in the Gunn rat 358
Neuro-inflammatory effects of photodegradative products of bilirubin 345
A new insight on the stem cell growth factor beta as astrong predictor of therapy response in hepatocellular carcinoma 326
Earliest mechanisms of dopaminergic neurons sufferance in a novel slow progressing ex vivo model of parkinson disease in rat organotypic cultures of substantia nigra 324
null 312
Anti-transglutaminase antibodies and age. 303
Management of restless legs syndrome in chronic liver disease: a challenge for the correct diagnosis and therapy 294
Thiamine and alcohol for brain pathology: super-imposing or different causative factors for brain damage? 283
Rescue of bilirubin-induced neonatal lethality in a mouse model of Crigler-Najjar syndrome type I by AAV9-mediated gene transfer. 281
Modulation of Mrp1 (ABCc1) and Pgp (ABCb1) by bilirubin at the blood-CSF and blood-brain barriers in the Gunn rat. 280
Abnormal apolipoprotein B pre-mRNA splicing in patients with familial hypobetalipoproteinaemia 274
A proteomic approach to the bilirubin-induced toxicity in neuronal cells reveals a protective function of DJ-1 protein. 274
Accuracy of body mass index in detecting an elevated alanine aminotransferase level in adolescents. 273
Podocyte expression of membrane transporters involved in puromycin aminonucleoside-mediated injury. 272
A simple index of lipid overaccumulation is a good marker of liver steatosis. 265
NOVEL BIOMARKERS FOR THE DIAGNOSIS OF LIVER FIBROSIS IN A HIGHLY RISK NAFLD COHORT in IFSO 2017 22(nd) World Congress 259
Heterologous ferredoxin reductase and flavodoxin protect Cos-7 cells from oxidative stress. 258
Overoxidation of peroxiredoxins as an immediate and sensitive marker of oxidative stress in HepG2 cells and its application to the redox effects induced by ischemia/reperfusion in human liver. 258
Rapid method for detection of extra (TA) in the promoter of Bilirubin-UDP-Glucuronosyl transferase 1 gene associated with Gilbert Syndrome 254
Identification and evaluation of novel non-invasive biomarkers for non-alcoholic fatty liver disease 254
HBV, HCV, and TTV detection by in situ polymerase chain reaction could reveal occult infection in hepatocellular carcinoma: comparison with blood markers 252
1H-NMR Spectroscopic Studies of Lipid Extracts from Human Fatty Liver 249
Alterations in the cell cycle in the cerebellum of hyperbilirubinemic gunn rat: a possible link with apoptosis? 246
Gene and functional up-regulation of the BCRP/ABCG2 transporter in hepatocellular carcinoma. 245
Alcohol-induced liver disease: From molecular damage to treatment. 245
TACE with cone beam computed tomography is more effective than traditional technique in BCLC A HCC patients ineligible to surgery 242
The role of ABC transporters in protecting cells from bilirubin toxicity 240
Modern strategies to identify new molecular targets for the treatment of liver diseases: The promising role of Proteomics and Redox Proteomics investigations 239
Life-long correction of hyperbilirubinemia with a neonatal liver-specific AAV-mediated gene transfer in a lethal mouse model of Crigler-Najjar Syndrome. 238
The Many Functions of APE1/Ref-1: Not Only a DNA Repair Enzyme 238
Blood flow changes in hepatocellular carcinomas after the administration of Thaliodomide by reperfusion kinetics during microbubble infusion: Preliminary results. 236
Homocysteine in neurology: From endothelium to Neurodegeneration 236
The cytotoxic effect of unconjugated bilirubin in human neuroblastoma SH-SY5Y cells is modulated by the expression level of MRP1 but not MDR1 235
Binding of tritiated bilirubin to albumin and plasma membrane vesicles: a reply 234
A simple in silico strategy identifies candidate biomarkers for the diagnosis of liver fibrosis in morbidly obese subjects 233
Neonatal hyperbilirubinemia 230
Predictors of non-alcoholic fatty liver disease in obese children 229
Alcohol, liver and genes: an intricate puzzle 229
Effect of tauroursodeoxycholic and ursodeoxycholic acid on ethanol-induced cell injuries in the human Hep G2 cell line 229
Albumin binding of 3H-unconjugated bilirubin and its uptake by rat liver basolateral plasma membrane vesicles 228
Stem cells compartment activation during hepatocarcinogenesis in a HBV-transgenic mouse model 227
Repeated double cross-validation applied to the PCA-LDA classification of SERS spectra: a case study with serum samples from hepatocellular carcinoma patients 226
Hepatic cancer stem cells and drug resistance: relevance in targeted therapies of hepatocellular carcinoma 225
Kinetics of the inflammatory response induced by free fatty acid accumulation in hepatocytes 225
A protective effect of breastfeeding on the progression of nonalcoholic fatty liver disease. 225
Liver and adipose tissue interplay through the up-regulation of the Th17 pathway 225
MiR-3201 as a Prognostic Blood Biomarker for Curative Treatments in Hepatocellular Carcinoma 224
Liver bromosulphonphthalein transport as a carrier mediated process 223
Functional induction of the cystine-glutamate exchanger system Xc(-) activity in SH-SY5Y cells by unconjugated bilirubin. 222
Anti-transglutaminase and age, Clinical Chemestry 221
Effect of intracellular lipid accumulation in a new model of non-alcoholic fatty liver disease. 221
Bilitranslocase is the protein responsible for the electrogenic movement of sulfobromo-phthalein in plasma membrane vesiscles from rat liver: immuno chemical evidence using mono and poly clonal antibodies 221
The pros and the cons for the use of Silybin-rich oral formulations in treatment of liver damage (NAFLD in particular) 220
Cancer stem cell markers analysis in a HBV-transgenic HCC mouse model 219
Biochemical investigations in the management of liver disease 219
Multidrug resistance in hepatic cancer stem cells: the emerging role of miRNAs 218
Bilirubin inhibits the TNFα-related induction of three endothelial adhesion molecules 218
Kinetics and specificity of feline leukemia virus subgroup C receptor (FLVCR) export function and its dependence on hemopexin. 217
Role of brain Cytochrome P450 mono-oxygenases in bilirubin oxidation - specific induction and activity. 217
Transport of sulfobromophthalein and taurocholate in the HepG2 cell line in relation to the expression of membrane carrier proteins. 216
Bilistick: A Low Cost Point-of-Care System to Measure Total Plasma Bilirubin 215
ATP-dependent transport of unconjugated bilirubin by rat liver canalicular plasma membrane vesicles 215
Recent insights on hepatic cancer stem cells. 214
Bilirubin mediated oxidative stress involves antioxidant response activation via Nrf2 pathway. 214
A comparative characterization of the circulating miRNome in whole blood and serum of HCC patients 214
Changing molecular epidemiology of hepatitis C virus infection in Northeast Italy. 213
Looking to the horizon: The role of bilirubin in development and prevention of age-related chronic diseases 213
Alcohol and Nutrition as Risk Factors for Chronic Liver Disease 212
Chronic administration of ursodeoxycholic and tauroursodeoxycholic acid changes microsomal membrane lipid content and fatty acid composition in rats 212
Specific Inhibition of the Redox Activity of Ape1/Ref-1 by E3330 Blocks Tnf-α-Induced Activation of Il-8 Production in Liver Cancer Cell Lines 212
Modulation of liver-specific cellular response to ethanol in vitro in Hep G2 cells. 211
A rational use of laboratory tests in the diagnosis and management of hepatitis C virus infection 210
Classical HLA-DRB1 and DPB1 alleles account for HLA associations with primary biliary cirrhosis. 209
Reconstitution in vitro of sulfobromophthalein transport by bilitranslocase 209
Body Mass Index is a good predictor of an elevated alanine transaminase level in the general population: Hints from the Dionysos study. 209
Differentiation between stages of non-alcoholic fatty liver diseases using surface-enhanced Raman spectroscopy 209
The spectrum of liver disease in the general population: Lesson from the Dionysos study. 207
The importance of the interaction between hepatocyte and hepatic stellate cells in fibrogenesis induced by fatty accumulation. 206
Oxidative Stress, Antioxidant Defenses, and the Liver. 205
Body Mass Index: from Quételet to evidence-based medicine 205
The Next Generation Sequencing (NGS) platform in the assessment of the gut microbiota in bariatric surgery. 205
Cohort effect of HCV infection in liver cirrhosis assessed by a 25 years study 204
The plasticity of the stem cells in the hepatocarcinogenesis and metastasis: study in vitro and in vivo 204
Spleen Stiffness Probability Index (SSPI): A simple and accurate method to detect esophageal varices in patients with compensated liver cirrhosis 204
The expression levels of the translational factors eEF1A 1/2 correlate with cell growth but not apoptosis in hepatocellular carcinoma cell lines with different differentiation grade 203
Clinical patterns of hepatocellular carcinoma in non alcoholic fatty liver disease: A multicenter prospective study 202
Totale 26.274
Salva come PNG Salva come JPEG
Categoria #
all - tutte 190.901
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 190.901
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021552 0 0 0 0 0 0 0 0 0 0 0 552
2021/20224.029 158 305 278 363 112 349 194 179 514 448 282 847
2022/20235.960 513 562 361 838 686 1.143 59 569 756 52 312 109
2023/20243.242 244 219 165 209 357 360 450 645 54 89 227 223
2024/20257.179 100 217 422 693 703 762 615 452 936 877 620 782
2025/202617.616 1.754 887 1.156 1.298 1.659 1.805 2.656 641 2.128 2.559 816 257
Totale 64.830